Abbott Laboratories Limited
Private and voluntary organisations · Private limited company
First report 13 Dec 2022•Latest report 13 Dec 2022
Reports, concerns and published responses
Reports over time
Reports naming this recipient by issue year.
* 2026 is projected from reports observed to 7 Sep 2026.
- Reports
- 1
- Published responses
- 100%
- Concerns addressed
- 1
- Stated actions
- 2
Naming this recipient
Found for named reports
Across all linked responses
Described in responses
Concerns and recipient responses
Statements from Abbott Laboratories Limited linked to the concerns in each report. Select any concern, action or position to view the source wording.
-
Concerns raised1
Failure to ensure that patients and carers understand the specific signs of sepsis
Actions described in response An action is something this recipient says it has done, is doing, or plans to do in response to the concern raised.2
-
Action
Ensure new patients seen by the ANA team receive updated sepsis-sign information, supplying the literature when patients do not have it.
-
Action
Carry and share Adult and Paediatric Symptom Cards with patients showing infection signs and their relevant family members or carers.
Respondent positions A position is what this recipient says about the concern when it does not describe a specific action.2
-
Position
Cardiff and Vale UHB is responsible for updating patient information and purchasing symptom cards addressing sepsis signs.
-
Position
Patient information may only be issued when authorised by Cardiff and Vale UHB under the existing contract specification.
Information checked against published PFD reports and official responses · Data reviewed 7 Sep 2026 · About data quality and limitations
Data last updated 7 September 2026